Study reveals liver-brain communication as key to managing circadian eating patterns and obesity

The collaboration will advance Verve Therapeutics’ in vivo gene editing programme targeting lipoprotein(a) to treat atherosclerotic cardiovascular disease. Credit: aodaodaodaod / Shutterstock.com. Verve Therapeutics and

When it came to excess U.S. deaths during the COVID pandemic, racial and ethnic disparities hit younger populations particularly hard, a cross-sectional study showed. People